CVS · CVS Health Corporation
Healthcare NYQ United States cvshealth.com ↗
BULLISH STRONG BUY
Val Gro Qua Mom Sta Cap P/S0.33 P/E Fwd P/E12.58 PEG0.30 52W –  RSI Target$112.19 (+5.9%) Beta0.60 Div2.43%
Loading chart…
RSI (14)
Pattern Overlays
Loading patterns…
Healthcare Plans Woonsocket, United States 219,000 employees
CVS Health Corporation provides health solutions in the United States. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health plans; medical management capabilities; Medicare Advantage and Medicare Supplement plans; prescription drug plans (PDPs); and Medicaid health care management services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. The Health Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, specialty and mail-order pharmacy, clinical services, disease management, medical spend management services, and pharmacy and other administrative services. It serves employers, insurance companies, unions, government employee groups, health plans, PDPs, Medicaid managed care plans, CMS, plans offered on public health insurance exchanges, and other sponsors of health benefit plans. The Pharmacy & Consumer Wellness segment sells prescription and over-the-counter drugs, consumer health and beauty products, personal care products, and other general merchandise products. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. It operates online retail pharmacy websites, retail specialty pharmacy stores, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
52-Week Range
52W Low 52W High
Position in Range
RSI (14)
0 · Oversold RSI 54 Overbought · 100
Signal Neutral
EMA Price Levels
Volume Analysis
Momentum Dashboard
Trend Strength
Detected Patterns
4Bullish
0Bearish
0Neutral
▲ Bull Flag — Breakout after +13% pole — bullish continuation
▲ Bull Flag — Breakout after +20% pole — bullish continuation
▲ Bull Flag — Breakout after +12% pole — bullish continuation
▲ Bull Flag — Breakout after +16% pole — bullish continuation

View overlays on the price chart via Chart tab → Pattern Overlays.

Next Earnings Aug 05, 2026
Beat Rate 88%
Consensus STRONG BUY
Analyst Upside +5.9%
EPS — History & Forecast
Estimate Beat Miss Forecast
Loading…
Revenue — History & Forecast
Revenue Forecast
Loading…
EPS Beat Rate
88% 7/8 quarters
Wall Street Consensus
STRONG BUY
24
4
BuyHoldSell
Price Target Range
$112.19 +5.9% upside
Low $79 High $148
Consensus Current price
Wall Street Analyst Ratings
FirmRatingChangeActionDate
UBS Buy ↔ Maintain 2026-07-25
Truist Securities Buy ↔ Maintain 2026-07-14
Wells Fargo Overweight ↔ Maintain 2026-07-13
RBC Capital Outperform ↔ Maintain 2026-07-09
Cantor Fitzgerald Overweight ↔ Maintain 2026-07-07
B of A Securities Buy ↔ Maintain 2026-06-23
Mizuho Outperform ↔ Maintain 2026-06-08
Morgan Stanley Overweight ↔ Maintain 2026-06-04
Barclays Overweight ↔ Maintain 2026-05-26
Bernstein Outperform ↔ Maintain 2026-05-13
JP Morgan Overweight ↔ Maintain 2026-05-12
TD Cowen Buy ↔ Maintain 2026-05-11
Evercore ISI Group Outperform ↔ Maintain 2026-05-07
Baird Outperform ↔ Maintain 2026-04-15
Piper Sandler Overweight ↔ Maintain 2026-03-31
Argus Research Buy ↔ Maintain 2026-01-28
UBS 2026-07-25
Buy ↔ Maintain
Truist Securities 2026-07-14
Buy ↔ Maintain
Wells Fargo 2026-07-13
Overweight ↔ Maintain
RBC Capital 2026-07-09
Outperform ↔ Maintain
Cantor Fitzgerald 2026-07-07
Overweight ↔ Maintain
B of A Securities 2026-06-23
Buy ↔ Maintain
Mizuho 2026-06-08
Outperform ↔ Maintain
Morgan Stanley 2026-06-04
Overweight ↔ Maintain
Barclays 2026-05-26
Overweight ↔ Maintain
Bernstein 2026-05-13
Outperform ↔ Maintain
JP Morgan 2026-05-12
Overweight ↔ Maintain
TD Cowen 2026-05-11
Buy ↔ Maintain
Evercore ISI Group 2026-05-07
Outperform ↔ Maintain
Baird 2026-04-15
Outperform ↔ Maintain
Piper Sandler 2026-03-31
Overweight ↔ Maintain
Argus Research 2026-01-28
Buy ↔ Maintain
Profitability
Gross Margin 13.39%TTM
Op. Margin 4.12%TTM
ROE 3.75%TTM
Rev. Growth 6.10%YoY
Free Cash Flow 5.20BTTM
FCF Yield TTM
Balance Sheet
Debt / Equity 100.91MRQ
Current Ratio 0.87MRQ
Cash 11.80BMRQ
Total Debt 78.35BMRQ
Net Debt MRQ
Income
Div. Yield 2.43%TTM
Annual Rate 2.66Fwd
Payout Ratio 116.67%TTM
Dividend History
Payout Ratio (TTM): 116.67%
DateAmount / ShareYield at Payment
2026-07-23 $0.6650 0.62%
2026-04-23 $0.6650 0.85%
2026-01-22 $0.6650 0.82%
2025-10-23 $0.6650 0.84%
2025-07-22 $0.6650 1.12%
2025-04-22 $0.6650 1.06%
2025-01-23 $0.6650 1.30%
2024-10-21 $0.6650 1.22%
2024-07-22 $0.6650 1.23%
2024-04-19 $0.6650 1.04%
2024-01-19 $0.6650 1.00%
2023-10-19 $0.6050 0.95%
2023-07-20 $0.6050 0.91%
2023-04-20 $0.6050 0.93%
2023-01-19 $0.6050 0.79%
2022-10-20 $0.5500 0.69%
2022-07-21 $0.5500 0.68%
2022-04-21 $0.5500 0.61%
2022-01-20 $0.5500 0.63%
2021-10-21 $0.5000 0.68%
2021-07-22 $0.5000 0.71%
2021-04-22 $0.5000 0.78%
2021-01-21 $0.5000 0.81%
2020-10-21 $0.5000 1.02%
2020-07-22 $0.5000 0.95%
2020-04-22 $0.5000 1.01%
2020-01-22 $0.5000 0.83%
2019-10-23 $0.5000 0.95%
2019-07-24 $0.5000 1.12%
2019-04-22 $0.5000 1.20%
2019-01-24 $0.5000 0.98%
2018-10-23 $0.5000 0.89%
2018-07-24 $0.5000 0.99%
2018-04-20 $0.5000 1.00%
2018-01-23 $0.5000 0.82%
2017-10-23 $0.5000 0.87%
2017-07-20 $0.5000 0.86%
2017-04-19 $0.5000 0.86%
2017-01-20 $0.5000 0.83%
2016-10-20 $0.4250 0.66%
How CVS Makes Its Money
Cash Flow Breakdown
Quarterly Metrics
QuarterRevenueRev YoYGross Profit Op. IncomeNet IncomeNet YoY Gross %Op %Net %
Full Key Statistics
Valuation
Market Cap135.15B
Enterprise Value201.87B
Trailing P/E47.93
Forward P/E12.58
PEG Ratio (5yr)0.30
Price/Sales (ttm)0.33
Price/Book (mrq)1.74
EV/Revenue0.50
EV/EBITDA13.10
Share Statistics
Avg Vol (3m)8.31M
Shares Outstanding1.28B
Float1.27B
% Held by Insiders0.06%
% Held by Institutions90.32%
Short Ratio2.47
Short % of Float1.54%
Profitability
Gross Margin13.39%
Operating Margin (ttm)4.12%
Profit Margin0.72%
Return on Assets (ttm)2.67%
Return on Equity (ttm)3.75%
Income Statement
Revenue (ttm)405.62B
Revenue Growth (yoy)6.10%
Gross Profit (ttm)54.30B
EBITDA15.41B
Net Income (ttm)2.93B
Diluted EPS (ttm)2.21
EPS Growth (yoy)63.10%
Balance Sheet
Total Cash (mrq)11.80B
Total Debt (mrq)78.35B
Debt / Equity (mrq)100.91
Current Ratio (mrq)0.87
Book Value / Share60.84
Operating CF (ttm)10.33B
Free Cash Flow (ttm)5.20B
Trading & Dividends
Beta (5Y)0.60
50-Day MA100.52
200-Day MA84.16
Fwd Dividend Yield243.00%
Payout Ratio116.67%
Ownership Breakdown
Institutional 90.32% Insider 0.06% Public 9.6%
Short Interest 1.54% of float
Low
Institutional 13F Holdings

Famous investors who disclosed a position in CVS in their latest SEC 13F filing.

Loading…
Insider Transactions
DateInsiderRoleTransactionSharesValue
2026-05-21 ROBBINS LARRY Director Sale at price 93.45 - 96.28 per share. 3,372,000 $317,471,136
2026-05-14 BALSER JEFFREY R M.D., PH.D. Director Stock Award(Grant) at price 97.15 per share. 2,058 $199,935
2026-05-14 SANSONE GUY P Director Stock Award(Grant) at price 97.15 per share. 1,447 $140,576
2026-05-14 BROWN C DAVID II Director Stock Award(Grant) at price 97.15 per share. 1,544 $150,000
2026-05-14 AGUIRRE FERNANDO Director Stock Award(Grant) at price 97.15 per share. 1,563 $151,845
2026-05-14 NORWALK LESLIE V Director Stock Award(Grant) at price 97.15 per share. 1,447 $140,576
2026-05-14 KIRBY JOHN SCOTT Director Stock Award(Grant) at price 97.15 per share. 1,447 $140,576
2026-05-08 MANDADI TILAK Officer Sale at price 89.58 per share. 69,551 $6,230,379
2026-03-31 COMPTON-PHILLIPS AMY Officer Stock Award(Grant) at price 71.82 per share. 5,569 $399,966
2026-03-31 CLARK JAMES DAVID Officer Stock Award(Grant) at price 71.82 per share. 11,138 $799,931
2026-03-31 NEWMAN BRIAN Chief Financial Officer Stock Award(Grant) at price 71.82 per share. 19,493 $1,399,987
2026-03-31 MANDADI TILAK Officer Stock Award(Grant) at price 71.82 per share. 22,277 $1,599,934
2026-03-31 SHAH PREM S Officer Stock Award(Grant) at price 71.82 per share. 25,062 $1,799,953
2026-03-31 NELSON STEVEN H Officer Stock Award(Grant) at price 71.82 per share. 22,277 $1,599,934
2026-03-31 JOYNER JOHN DAVID Chief Executive Officer Stock Award(Grant) at price 71.82 per share. 86,326 $6,199,933
2026-03-31 KHICHI SAMRAT S General Counsel Stock Award(Grant) at price 71.82 per share. 12,531 $899,976
2026-03-31 CAPOZZI HEIDI B Officer Stock Award(Grant) at price 71.82 per share. 10,025 $719,996
2026-03-19 GALLINA JOHN E Director Stock Award(Grant) at price 71.86 per share. 582 $41,823
2025-11-20 BALSER JEFFREY R M.D., PH.D. Director Stock Award(Grant) at price 76.04 per share. 1,775 $134,971
2025-11-20 FINUCANE ANNE A Director Stock Award(Grant) at price 76.04 per share. 591 $44,940
2025-11-20 BROWN C DAVID II Director Stock Award(Grant) at price 76.04 per share. 1,775 $134,971
2025-11-20 AGUIRRE FERNANDO Director Stock Award(Grant) at price 76.04 per share. 1,800 $136,872
2025-11-20 SANSONE GUY P Director Stock Award(Grant) at price 76.04 per share. 1,652 $125,618
2025-11-20 NORWALK LESLIE V Director Stock Award(Grant) at price 76.04 per share. 1,652 $125,618
2025-11-20 SHULMAN DOUGLAS H Director Stock Award(Grant) at price 76.04 per share. 1,652 $125,618
ROBBINS LARRY Director
Sale at price 93.45 - 96.28 per share.
2026-05-21 3,372,000 sh $317,471,136
BALSER JEFFREY R M.D., PH.D. Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 2,058 sh $199,935
SANSONE GUY P Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 1,447 sh $140,576
BROWN C DAVID II Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 1,544 sh $150,000
AGUIRRE FERNANDO Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 1,563 sh $151,845
NORWALK LESLIE V Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 1,447 sh $140,576
KIRBY JOHN SCOTT Director
Stock Award(Grant) at price 97.15 per share.
2026-05-14 1,447 sh $140,576
MANDADI TILAK Officer
Sale at price 89.58 per share.
2026-05-08 69,551 sh $6,230,379
COMPTON-PHILLIPS AMY Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 5,569 sh $399,966
CLARK JAMES DAVID Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 11,138 sh $799,931
NEWMAN BRIAN Chief Financial Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 19,493 sh $1,399,987
MANDADI TILAK Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 22,277 sh $1,599,934
SHAH PREM S Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 25,062 sh $1,799,953
NELSON STEVEN H Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 22,277 sh $1,599,934
JOYNER JOHN DAVID Chief Executive Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 86,326 sh $6,199,933
KHICHI SAMRAT S General Counsel
Stock Award(Grant) at price 71.82 per share.
2026-03-31 12,531 sh $899,976
CAPOZZI HEIDI B Officer
Stock Award(Grant) at price 71.82 per share.
2026-03-31 10,025 sh $719,996
GALLINA JOHN E Director
Stock Award(Grant) at price 71.86 per share.
2026-03-19 582 sh $41,823
BALSER JEFFREY R M.D., PH.D. Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,775 sh $134,971
FINUCANE ANNE A Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 591 sh $44,940
BROWN C DAVID II Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,775 sh $134,971
AGUIRRE FERNANDO Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,800 sh $136,872
SANSONE GUY P Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,652 sh $125,618
NORWALK LESLIE V Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,652 sh $125,618
SHULMAN DOUGLAS H Director
Stock Award(Grant) at price 76.04 per share.
2025-11-20 1,652 sh $125,618